A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Obesity & Overweight, Weight Loss, Metabolic Syndrome, Metabolic Dysfunction-Associated Steatohepatitis. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Taiwan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This prospective cohort study collected baseline data and followed up obese patients at their first visit to a weight loss clinic. The study examined the impact of various predictors and biomarkers on weight loss outcomes, aiming to establish an evidence-based foundation for personalized weight loss treatment. Participants underwent a battery of measurements and questionnaires, including height, weight, waist circumference, blood pressure, blood tests, and questionnaires addressing diet, exercise, stress, sleep, measure handgrip strength ,and psychological well-being.
Primary outcome measures
- Baseline data were collected and followed up during the subjects' initial visit to the weight loss clinic to establish an evidence-based basis for personalized weight reduction treatment. [Time frame: Weight changes of subjects after 24 weeks, 48 weeks, 72 weeks, and 96 weeks.]
Eligibility criteria
Inclusion criteria
- Adults aged 18 years or older, regardless of gender.
- Body mass index (BMI) ≥ 27 kg/m², or ≥ 24 kg/m² with one or more obesity-related comorbidities.
- Willing to undergo any form of weight loss intervention.
- Able to read and understand Chinese, willing to complete questionnaires, blood tests, and follow-up follow-up.
- Voluntarily consent to participate and be willing to complete the subject consent form.
Exclusion criteria
- Pregnant or breastfeeding women.
- Individuals with significant mental illness (e.g., schizophrenia, severe depression) or cognitive impairment that may affect their ability to consent or cooperate with the study.
- Individuals with severe organ dysfunction (e.g., end-stage renal disease, cirrhosis, congestive heart failure, etc.).
- Individuals taking medications that significantly affect their weight (e.g., long-term steroids or antipsychotics) and cannot be discontinued.
- Individuals deemed unsuitable for participation in this study by the study leader (e.g., individuals who are expected to be unable to complete follow-up).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Taiwan · 1 center
- No.7, Chung Shan S. Rd.（Zhongshan S. Rd.） — Taipei
Identifiers
NCT: NCT07239167 · 202504134RINA